all glp-1 drugs Costs Explained: Managing Coverage Challenges Indications for GLP-1/GIP RA Summary
Description
We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome
Semaglutide works in a similar way by helping to slow down how quickly food leaves the stomach and by acting on areas of the brain involved in appetite control
We categorised participants based on their response: HbA1c reduction only, weight loss only, both or neither
GLP-1= glucagon-like peptide-1
They mimic the natural GLP-1 hormone, helping people feel fuller, eat less and improve post-meal glucose control (Collins 2024
